Evaluating Systemic Immune-Inflammation Index and Mortality in Diabetic Retinopathy: A NHANES 2005–2018 Cohort Study

Key Points

• To evaluate the relationship between systemic immune inflammation and mortality risk in individuals with diabetic retinopathy.
• Utilized NHANES data from 2005 to 2018
• Assessed levels of systemic immune inflammation
• Analyzed mortality risk in adults diagnosed with diabetic retinopathy
• Elevated immune inflammation is linked to higher mortality risk
• Findings indicate potential as a prognostic biomarker for diabetic retinopathy
• Results highlight limitations of traditional risk factors in predicting mortality